Serotonin News and Research

Latest Serotonin News and Research

New study could help optimize SSRI dosing and minimize adverse effects in teens

In a simulated study, exposure to and maximum blood concentrations of two selective serotonin reuptake inhibitors - commonly used to treat anxiety and depression in adolescents - differed depending on whether the teens modeled were poor, normal, rapid, or ultra-rapid metabolizers of the SSRIs.

9 Apr 2019

Study uncovers genetic causes of poor sleep

The international collaboration, led by the University of Exeter and published in Nature Communications, has found 47 links between our genetic code and the quality, quantity and timing of how we sleep. They include ten new genetic links with sleep duration and 26 with sleep quality.

5 Apr 2019

New study debunks link between depression risk and 18 genes

Over the past quarter-century, researchers have published hundreds of studies suggesting a small set of particular genes or gene-variants plays a substantial role in boosting susceptibility to depression.

3 Apr 2019

Study explores how a hallucinogenic drug impacts the brains of mice

While there is increasing interest in using hallucinogenic drugs to treat conditions like depression and post-traumatic stress disorder, scientists are just beginning to understand what these drugs actually do in the brain—and how they cause hallucinations.

27 Mar 2019

Antidepressant drugs may not work when neurons are out of shape

elective serotonin reuptake inhibitors are the most commonly prescribed medication for major depressive disorder, yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.

22 Mar 2019

Study provides new understanding of how the brain recovers from damage caused by stroke

Each year, approximately 265,000 Americans have a stroke that causes visual impairment. New research, which appears in the journal Proceedings of the Royal Society B, sheds light on how the damage in the brain caused by a stroke can lead to permanent vision impairment.

21 Mar 2019

Roundworm study suggests alternatives for treatment of schizophrenia

A group of Brazilian scientists have long conducted experiments with roundworms to investigate the role of schizophrenia-linked genes in patients' response to antipsychotic drugs. The results obtained thus far point to new ways of understanding resistance to certain classes of medication.

20 Mar 2019

Researchers measure brain metabolite levels in people with mild memory problems

Using strong and targeted but noninvasive magnets at specific sites in the brains of people with and without mild learning and memory problems, Johns Hopkins researchers report they were able to detect differences in the concentrations of brain chemicals that transmit messages between neurons.

20 Mar 2019

Columbia researchers explore molecular mechanisms of treatment-resistant depression

Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.

14 Mar 2019

Review of research evidence suggests increased suicide rates in high-altitude areas

High-altitude areas - particularly the US intermountain states - have increased rates of suicide and depression, suggests a review of research evidence in the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.

11 Mar 2019

Mother's treatment for infection during pregnancy increases child's risk for autism and depression

Risks for autism and depression are higher if one's mother was in hospital with an infection during pregnancy. This is shown by a major Swedish observational study of nearly 1.8 million children.

8 Mar 2019

Esketamine nasal spray approved for management of treatment-resistant depression

The United States Food and Drugs Administration (FDA) have approved for sale a new nasal spray containing Esketamine for the management of treatment-resistant depression.

6 Mar 2019

Researchers discover facile method for introduction of fluorine atoms into organic molecules

The vast majority of pharmaceuticals employed in the treatment of human diseases are of an organic nature, meaning that the active component is a molecule (or a combination of several molecules) that is constituted of carbon and hydrogen atoms.

6 Mar 2019

Research finds steep rise in self-poisonings among young people

Self-harm from self-poisoning in children and adolescents is not only increasing but starting at a younger age, finds new research by University of Sydney and the NSW Poisons Information Centre.

20 Feb 2019

Brain imaging indicates potential success of drug therapy in depressive patients

Working with international partners, a MedUni Vienna research group has shown that imaging techniques carried out prior to treatment indicate the potential success of drug therapy in depressive patients.

19 Feb 2019

Activating gene that helps excite neurons reverses depression in male mice

Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.

18 Feb 2019

Researchers use optogenetic tool to control, visualize receptor signals in neural cells

Using a novel optogenetic tool, researchers have successfully controlled, reproduced and visualized serotonin receptor signals in neural cells. To this end, they modified a photosensitive membrane receptor in the eye, namely melanopsin.

15 Feb 2019

Researchers identify brain pathways of aversion

What happens in the brain when we feel discomfort? Researchers at Karolinska Institutet in Sweden are now one step closer to finding the answer. In a new study published in the journal Molecular Psychiatry they identify which pathways in the mouse brain control behavior associated with aversion.

14 Feb 2019

Researchers report promising advance in the search for new class of antidepressants

In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression.

8 Feb 2019

Physical activity may help fight depression in seniors

The benefits of exercise are widely known but kinesiologists at McMaster University have for the first time found that physical activity may help fight depression in seniors by stimulating muscle-generated mood boosters.

8 Feb 2019

Serotonin News and Research

Latest Serotonin News and Research

New study could help optimize SSRI dosing and minimize adverse effects in teens

Study uncovers genetic causes of poor sleep

New study debunks link between depression risk and 18 genes

Study explores how a hallucinogenic drug impacts the brains of mice

Antidepressant drugs may not work when neurons are out of shape

Study provides new understanding of how the brain recovers from damage caused by stroke

Roundworm study suggests alternatives for treatment of schizophrenia

Researchers measure brain metabolite levels in people with mild memory problems

Columbia researchers explore molecular mechanisms of treatment-resistant depression

Review of research evidence suggests increased suicide rates in high-altitude areas

Mother's treatment for infection during pregnancy increases child's risk for autism and depression

Esketamine nasal spray approved for management of treatment-resistant depression

Researchers discover facile method for introduction of fluorine atoms into organic molecules

Research finds steep rise in self-poisonings among young people

Brain imaging indicates potential success of drug therapy in depressive patients

Activating gene that helps excite neurons reverses depression in male mice

Researchers use optogenetic tool to control, visualize receptor signals in neural cells

Researchers identify brain pathways of aversion

Researchers report promising advance in the search for new class of antidepressants

Physical activity may help fight depression in seniors

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Serotonin News and Research

Latest Serotonin News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in